The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Andorin A, Gourraud JB, Mansourati J, Fouchard S, le Marec H, Maury P, Mabo P, Hermida JS, Deharo JC, Delasalle B, Esnault S, Sadoul N, Davy JM, Leenhardt A, Klug D, Defaye P, Babuty D, Sacher F, Probst V.
Andorin A, et al. Among authors: esnault s.
Heart Rhythm. 2017 Aug;14(8):1147-1154. doi: 10.1016/j.hrthm.2017.04.019. Epub 2017 Apr 12.
Heart Rhythm. 2017.
PMID: 28411139
Clinical Trial.